Chemring Group (CHG)

Sector:

Defense and Aeronautics

Index:

FTSE 250

373.50p
   
  • Change Today:
      8.50p
  • 52 Week High: 374.50
  • 52 Week Low: 255.50
  • Currency: UK Pounds
  • Shares Issued: 272.35m
  • Volume: 476,827
  • Market Cap: £1,017.25m
  • RiskGrade: 157

Chemring backs full-year expectations

By Michele Maatouk

Date: Wednesday 04 Mar 2020

LONDON (ShareCast) - (Sharecast News) - Chemring backed its full-year expectations on Wednesday as it said current trading has been in line with expectations in both segments and that it had not seen a material impact to its business yet from the coronavirus outbreak.
In an update ahead of its annual general meeting, the company said it continues to make good progress in the execution of its strategy and is well placed to take advantage of the growth opportunities available.

"The backdrop of continued geopolitical unrest supports the need for government spending on defence and national security in all our target markets," it said.

In the key US market, current defence spending, future 2021 budget and longer-term projections to 2025 remain at high levels, it noted, adding that 2020 defence budget may lead to the US Department of Defence buying additional F-35 Joint Strike Fighters.

Chemring said continuing order intake in the period to 29 February 2020 was ?132m, up from ?120m in 2019, with a book to bill ratio of 125% versus 154% a year ago. Meanwhile, the order book for continuing operations stood at ?478m at 29 February compared to ?421m a year earlier.

In the sensors & information business, Roke continues to see growing demand for its services and the US Programs of Record continue to progress in line with the group's expectations.

In the countermeasures & energetics division, Chemring's Australian facility has successfully delivered its first batches of training countermeasures for the F-35 program to the US Department of Defence and has begun production of the first batch of operational countermeasures.

The company said its UK facility continues to ramp up output following the phased restart in 2019 and is now focused on operational efficiency. In the US, its focus has been on its capital investment programme in Tennessee which, when commissioned in the second half of next year, will provide additional automated capacity for the manufacture of F-35 countermeasures.

Chemring said the coronavirus outbreak is not currently having any material impact on its businesses or supply chains. However, it is monitoring the situation "closely".

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Chemring Group Market Data

Currency UK Pounds
Share Price 373.50p
Change Today 8.50p
% Change 2.33 %
52 Week High 374.50
52 Week Low 255.50
Volume 476,827
Shares Issued 272.35m
Market Cap £1,017.25m
RiskGrade 157

Chemring Group Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
91.95% below the market average91.95% below the market average91.95% below the market average91.95% below the market average91.95% below the market average
20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average
Price Trend
84.73% above the market average84.73% above the market average84.73% above the market average84.73% above the market average84.73% above the market average
27.27% below the sector average27.27% below the sector average27.27% below the sector average27.27% below the sector average27.27% below the sector average
Income
64.96% below the market average64.96% below the market average64.96% below the market average64.96% below the market average64.96% below the market average
25.00% above the sector average25.00% above the sector average25.00% above the sector average25.00% above the sector average25.00% above the sector average
Growth
44.11% below the market average44.11% below the market average44.11% below the market average44.11% below the market average44.11% below the market average
60% below the sector average60% below the sector average60% below the sector average60% below the sector average60% below the sector average

What The Brokers Say

Strong Buy 5
Buy 1
Neutral 0
Sell 1
Strong Sell 0
Total 7
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Chemring Group Dividends

  Latest Previous
  Final Interim
Ex-Div 21-Mar-24 17-Aug-23
Paid 12-Apr-24 08-Sep-23
Amount 4.60p 2.30p

Trades for 26-Apr-2024

Time Volume / Share Price
16:35 142,000 @ 373.50p
16:35 839 @ 373.50p
16:35 1,334 @ 373.50p
16:35 551 @ 373.50p
16:35 130 @ 373.50p

Chemring Group Key Personnel

CFO James Mortensen

Top of Page